Rezultati pretraživanja
  1. prije 46 minuta

    Good summary of 's planned spinoff and separation intentions - Dividing into two companies - One R&D-focused company - One consumer health company through JV with (+maybe the prescription derm business) - Cost is £2.4B over 2 years

    Prikaži ovu nit
  2. prije 3 sata
  3. Jefferson Institute for Bioprocessing and  have partnered to create the JIB-BCG Digital Demonstrator for digital innovation in operations. The demonstrator is the first of its kind in the US. Learn more ▶️

  4. prije 8 sati
  5. At ClearLight Biotechnologies we enable modern heroes to see more biology and explore further with Tru3D™. Get Started with CLARITY and Tru3D.

  6. prije 9 sati

    By focusing on high touch services that can help enhance patient outcomes, and life sciences companies can overcome the market access challenges faced by orphan drugs. Download our white paper to learn more:

  7. prije 9 sati

    The industry provides 196,000 high-skill, high-wage jobs in Texas. See new video featuring @ TXManufacturers

  8. prije 10 sati

    Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells:

  9. prije 10 sati

    Partner Daniel Shores and other experts discussed the increasingly important field of at a event this morning, including whether to seek or trade secret protection for your invention and the future role of trade secrets in and .

  10. prije 10 sati

    Good news for patients with rare and fatal heart disease....and good news for Pfizer

  11. prije 11 sati

    What if you could increase your visibility with healthcare providers and sponsored sites to accelerate trials to completion?

  12. How can companies optimize processes to ensure the successful launch of strong products? We explain here:

  13. simply explained! Thermo Scientific

  14. prije 13 sati
  15. prije 14 sati

    Is this Merck being a focused player or a leaner player?

  16. prije 14 sati

    Could biologics be delivered orally? Recent research suggests some strategies that may make it possible:

  17. We are a trusted partner to some of the world’s leading & companies, for whom maintaining the cold chain is a matter of patient safety.

  18. Ancestral sequence reconstruction gives thermostable candidates as scaffolds for potential therapeutic applications!

  19. 4. velj

    How this company wants to change how we treat pain:

  20. What are the key drivers that could help deliver a sustainable future for R&D? Find out in our latest report:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.